[Analgesic effects of H1 receptor antagonists in the rat model of formalin-induced pain].
OBJECTIVE
Histamine receptors mediate nociceptive pathways, especially in the central nervous system. Some studies have demonstrated the analgesic effects of histamine receptor antagonists in the peripheral nervous system. It is not clear whether the local analgesic effect is class-specific or drug-specific.


METHODS
To answer this question, we used three different H1 receptor antagonists (pyrilamine, promethazine, and cetirizine) administered directly in the paw of the rat, intraperitoneally, or in peripheral nerve blockade in the formalin-induced pain model. The effects of the drugs on the number of paw elevations were observed.


RESULTS
In phase I, the local administration of pyrilamine caused a dose-dependent reduction on the number of paw elevations; in the highest dose, the number of paw elevations was reduced by 97.8%. Promethazine decreased it by 92%, while cetirizine decreased by 23.9%. In phase II, pyrilamine decreased the number of paw elevations by 93.5%, promethazine by 78.2%, and cetirizine by 80.1%. Intraperitoneal administration of drugs did not change painful behavior. When used in peripheral nerve block, in phase I pyrilamine reduced the number of paw elevations by 96.7%, promethazine by 73.3%, and cetirizine by 23.9%. In phase II, pyrilamine reduced the number of paw elevations by 86.6%, promethazine by 64.4%, and cetirizine by 19.9%.


CONCLUSIONS
The results demonstrate that H1 receptor antagonists have local analgesic effects, different from the systemic effects, one of them an anti-inflammatory and class-specific effect and the other similarly to the local anesthetic effect, specific for promethazine and pyrilamine.
Ashmawi
Hazem Adel
HA
Departamento de Medicina, Universidade Federal de São Carlos. hazem@hcnet.usp.br
Braun
Leandro Mamede
LM
Sousa
Angela Maria
AM
Posso
Irimar de Paula
Ide P
D000698:Analgesia; D000818:Animals; D004195:Disease Models, Animal; D005557:Formaldehyde / Q000008:administration & dosage; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D008297:Male; D010146:Pain / Q000139:chemically induced / Q000517:prevention & control*; D051381:Rats; D017208:Rats, Wistar
D006634:Histamine H1 Antagonists; D005557:Formaldehyde